کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4355376 | 1615619 | 2011 | 10 صفحه PDF | دانلود رایگان |
After almost seven decades in clinical use, aminoglycoside antibiotics still remain indispensible drugs for acute infections and specific indications such as tuberculosis or the containment of pseudomonas bacteria in patients with cystic fibrosis. The review will describe the pathology and pathophysiology of aminoglycoside-induced auditory and vestibular toxicity in humans and experimental animals and explore contemporary views of the mechanisms of cell death. It will also outline the current state of protective therapy and recent advances in the development of aminoglycoside derivatives with low toxicity profiles for antimicrobial treatment and for stop-codon suppression in the attenuation of genetic disorders.
► We first analyze the current use of aminoglycoside antibiotics.
► We detail the physiological and molecular pathology of hearing loss.
► We evaluate the current status of protective therapy.
► The outlook for novel antibiotics and novel therapeutic applications is discussed.
Journal: Hearing Research - Volume 281, Issues 1–2, November 2011, Pages 28–37